Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models

por Predina, J D, Judy, B, Aliperti, L A, Fridlender, Z G, Blouin, A, Kapoor, V, Laguna, B, Nakagawa, H, Rustgi, A K, Aguilar, L, Aguilar-Cordova, E, Albelda, S M, Singhal, S
Publicado 2011